Implantable Devices
Feb 09, 2016
Medicare's final decision memo on reimbursement coverage for percutaneous left atrial appendage closure therapy is more forgiving than its November...
Feb 08, 2016
Marie Thibault St. Jude Medical's current Portico TAVR, has CE Mark and is being studied in the U.S. IDE trial. So far, 2016 looks like a good year for St...
Feb 05, 2016
FDA has approved the first MR-conditional cardiac resynchronization therapy - defibrillator devices in the U.S. made by Medtronic. Arundhati Parmar...
Feb 05, 2016
Marie Thibault No matter what Medicare decides, Boston Scientific executives still see a big market for the Watchman left atrial appendage closure (LAAC)...
Feb 03, 2016
Holiday sales of Edwards Lifesciences' transcatheter aortic valve replacement systems were unusually high last year. Arundhati Parmar Undergoing a cardiac...
Jan 27, 2016
Arundhati Parmar   News reports about Stryker, which reported its fourth-quarter earnings on Tuesday, generally centered around the company's...
Jan 15, 2016
Edwards Lifesciences is embarking upon a clinical trial in the U.S. to test its latest transcatheter heart valve on younger patients with severe aortic...
Jan 12, 2016
Marie Thibault 2016 is off to a slow start for MVAD, the next-generation left ventricular assist device (LVAD) being developed by HeartWare. After the company...
Jan 07, 2016
LDR Holdings is the only company to have an artificial cervical disc approved by the FDA for both one-level and two-level indications of degenerative...
Dec 17, 2015
Marie Thibault A month after CMS released a tough proposal decision memo on reimbursement for Boston Scientific's Watchman left atrial appendage closure (...